Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) reported earnings of ($0.44) per share missing Walls Streets expectations.

ME Staff
-
0

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) reported Q2 earnings this Morning, coming in at ($0.44) per share, missing Wall Street’s estimates of ($0.39) per Share. Revenue for the quarter came in at $0.80 million missing the streets estimates of $1.50 million

Analyst Coverage For Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)
These are 2 Buy Ratings .
The current consensus rating for Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is Buy (Score: 3.00) with a consensus target price of $14.50 , a potential (226.58% upside)



      Recent Trading for Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)
      Shares of Foamix Pharmaceuticals Ltd. closed the previous trading session at 4.44 down -0.15 -3.27% with 140,081 shares trading hands.